Literature DB >> 7690123

Beneficial effect of prolonged administration of albumin on ischemic cerebral edema and infarction after occlusion of middle cerebral artery in rats.

T Matsui1, H Sinyama, T Asano.   

Abstract

This study compared the therapeutical effect of the prolonged administration of albumin, 2 g/kg body weight per day, with that of saline or dextran, 0.8 g/kg body weight per day, on cerebral ischemia, using an occlusion of the middle cerebral artery in the rat. Brain water, sodium, and potassium contents were measured 72 hours after middle cerebral artery occlusion. The volume of infarction was represented as volume index, which is a total of the infarction area measured in the five brain slices at 168 hours after middle cerebral artery occlusion. The postischemic administration of albumin at the dose tested elucidated an antiedema effect and reduced the infarction size after regional ischemia in rats. These results strongly support the idea that hemodilution therapy with colloids such as albumin has wide usage as a treatment of patients with ischemic cerebral stroke.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690123     DOI: 10.1227/00006123-199308000-00017

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 2.  Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".

Authors:  Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  The effects of the pretreatment of intravenous high dose methylprednisolone on Na(+)-K(+)/Mg(+2) ATPase and lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat.

Authors:  F Ildan; S Polat; A I Göcer; A Oner; T Isbir; U O Mete; M Kaya; A Karadayi
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Neuroprotective effect of DAHK peptide in an occlusive model of permanent focal ischemia in rats.

Authors:  Araceli Díaz-Ruíz; Camilo Ríos; Joselyn Carvajal-Sotelo; Alma Ortiz-Plata; Gerardo Pavel Espino-Solis; Marisela Méndez-Armenta; Sergio Montes; Antonio Monroy-Noyola
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

Review 5.  Multifunctional actions of approved and candidate stroke drugs.

Authors:  Jens Minnerup; Wolf-Rüdiger Schäbitz
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 6.  Aspects on the Physiological and Biochemical Foundations of Neurocritical Care.

Authors:  Carl-Henrik Nordström; Lars-Owe Koskinen; Magnus Olivecrona
Journal:  Front Neurol       Date:  2017-06-19       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.